Our hypothesis is that YKL-40 may have synergistic effects; on HFs, it can act similarly to insulin-like growth factor-1, leading to an inflammatory condition and promoting an up-regulation in MMP-1 expression, in order to remodel the extracellular matrix. The gene discussed is IGF1; the disease is Hand-foot syndrome.